Each peptide that’s recommended this week represents the possibility of a new profit stream for compounders and telehealth companies. By some estimates, the total market for these seven peptides could be worth billions of dollars. And, if they’re ultimately approved, it will also serve as another example of Kennedy getting his way over the objections of the researchers who work for him.